Literature DB >> 9823482

Dopamine innervation of a subclass of local circuit neurons in monkey prefrontal cortex: ultrastructural analysis of tyrosine hydroxylase and parvalbumin immunoreactive structures.

S R Sesack1, V A Hawrylak, D S Melchitzky, D A Lewis.   

Abstract

The ability of dopamine to regulate the cognitive functions of the prefrontal cortex (PFC) involves complex modulatory actions on GABA-containing local circuit neurons in addition to pyramidal cells. However, the subclasses of cortical neurons that receive direct dopamine input are not known. We sought to determine whether dopamine terminals innervate the subclasses of local circuit neurons that contain the calcium-binding protein parvalbumin (PV), namely the wide arbor and chandelier neurons that target pyramidal cell soma and axon initial segments respectively. Sections through area 9 of five monkeys were labeled with immunoperoxidase for tyrosine hydroxylase (TH), to identify dopamine terminals, and with immunogold-silver for PV. Electron microscopic examination of the middle cortical layers (IIIb-IV) revealed that TH-positive terminals were sometimes directly apposed to PV-labeled dendrites, and approximately one-third of these contacts exhibited morphological features that are typically associated with symmetric synapses. In contrast, TH-immunolabeled terminals in the superficial layers (I-IIIa) were less frequently apposed to PV-positive dendrites, and none of these contacts exhibited synapse-like morphology. These findings, in concert with previous studies of GABA- or calretinin-containing local circuit neurons, suggest that dopamine's modulatory action in the PFC involves selective effects on only certain interneuron populations, including those that mediate potent inhibitory actions on pyramidal cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9823482     DOI: 10.1093/cercor/8.7.614

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  33 in total

Review 1.  The histophysiology of neocortical basket cells.

Authors:  V E Okhotin; S G Kalinichenko
Journal:  Neurosci Behav Physiol       Date:  2002 Sep-Oct

2.  Dopamine terminals in the rat prefrontal cortex synapse on pyramidal cells that project to the nucleus accumbens.

Authors:  D B Carr; P O'Donnell; J P Card; S R Sesack
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

3.  Altered dendritic distribution of dopamine D2 receptors and reduction in mitochondrial number in parvalbumin-containing interneurons in the medial prefrontal cortex of cannabinoid-1 (CB1) receptor knockout mice.

Authors:  Megan L Fitzgerald; June Chan; Kenneth Mackie; Carl R Lupica; Virginia M Pickel
Journal:  J Comp Neurol       Date:  2012-12-01       Impact factor: 3.215

4.  Pharmacological Manipulation of Cortical Inhibition in the Dorsolateral Prefrontal Cortex.

Authors:  Bahar Salavati; Tarek K Rajji; Reza Zomorrodi; Daniel M Blumberger; Robert Chen; Bruce G Pollock; Zafiris J Daskalakis
Journal:  Neuropsychopharmacology       Date:  2017-05-29       Impact factor: 7.853

5.  Brief dopaminergic stimulations produce transient physiological changes in prefrontal pyramidal neurons.

Authors:  Anna R Moore; Wen-Liang Zhou; Evgeniy S Potapenko; Eun-Ji Kim; Srdjan D Antic
Journal:  Brain Res       Date:  2010-11-06       Impact factor: 3.252

6.  Differential postnatal development of catecholamine and serotonin inputs to identified neurons in prefrontal cortex of rhesus monkey.

Authors:  E K Lambe; L S Krimer; P S Goldman-Rakic
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

Review 7.  The anatomy of co-morbid neuropsychiatric disorders based on cortico-limbic synaptic interactions.

Authors:  S Totterdell
Journal:  Neurotox Res       Date:  2006-10       Impact factor: 3.911

Review 8.  Dopamine's Actions in Primate Prefrontal Cortex: Challenges for Treating Cognitive Disorders.

Authors:  Amy F T Arnsten; Min Wang; Constantinos D Paspalas
Journal:  Pharmacol Rev       Date:  2015-07       Impact factor: 25.468

Review 9.  Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction.

Authors:  Patricia S Goldman-Rakic; Stacy A Castner; Torgny H Svensson; Larry J Siever; Graham V Williams
Journal:  Psychopharmacology (Berl)       Date:  2004-04-30       Impact factor: 4.530

Review 10.  Pharmacogenetic tools for the development of target-oriented cognitive-enhancing drugs.

Authors:  José A Apud; Daniel R Weinberger
Journal:  NeuroRx       Date:  2006-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.